As expected, the results revealed that silencing NEAT1 in GC cells markedly decreased expression level of TGFβR2, P-Smad2, P-Smad3, and VEGF, pivotal indicators of TGF-β/smad pathway activity. This evidence concerns the gene TGFB1 and gastric cancer.